12月7日，Choice数据显示，南向资金截至12月6日持有金斯瑞生物科技5.25亿股，持股市值58.98亿港元，较上个交易日增加9906.46万港元，持股数量占发行股的24.53%。

截至6日收盘，金斯瑞生物科技当日上涨2%，收盘价报11.24港元。

大事提醒

2024年12月4日，戴祖勉于2024-12-04减持5871.00股，每股均价10.9364港元，最新持股数目10.15万股 @#$ On 18/1/2023, Mr. Dai Zumian was granted restricted shares underlying 14,929 shares of Genscript Biotech Corporation, of which the last batch will be vested on 17/12/2025 and 4,478 shares were vested on 17/12/2023. On 28/11/2023, Mr. Dai Zumian was granted restricted shares underlying 34,409 shares of the Company and those shares were vested in one batch on 30/11/ 2024, which were exercised on 4/12/2024 and 5,871 shares thereof were sold to cover the tax and expense。

本文源自：金融界

作者：智投君